In a resident receiving comfort‑measures‑only care for osteomyelitis (including methicillin‑resistant Staphylococcus aureus, Pseudomonas aeruginosa, and anaerobes), should systemic antibiotics be continued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Discontinue Systemic Antibiotics in Comfort-Measures-Only Care for Osteomyelitis

In a resident receiving comfort-measures-only care for osteomyelitis, systemic antibiotics should generally be discontinued unless they are specifically needed for symptom palliation or the patient/family explicitly requests continuation after informed discussion of benefits and harms. 1

Rationale for Discontinuation

The primary goal of comfort-measures-only care is symptom relief and quality of life, not infection eradication. 1 Osteomyelitis requires prolonged antibiotic therapy (≥4–6 weeks) combined with surgical debridement for cure, which is incompatible with comfort-focused goals. 2, 3 Without surgical resection of infected bone, antibiotics alone cannot achieve remission and must be continued indefinitely. 2

Continuing antibiotics in this setting exposes the patient to unnecessary harms without meaningful benefit:

  • Adverse effects: IV access complications, drug toxicity, Clostridioides difficile infection, and antimicrobial resistance. 1, 4
  • Medicalization of dying: Prolonging interventions that do not improve comfort or quality of life. 1, 4
  • False hope: Antibiotics may create unrealistic expectations of recovery when the focus should be on comfort. 1

When to Consider Continuation

Two specific scenarios may justify continuing antibiotics in comfort care:

1. Symptom Palliation

If the patient has fever, pain, or purulent drainage that is clearly distressing and antibiotics demonstrably improve these symptoms, a short course (3–7 days) may be appropriate. 1 However, osteomyelitis symptoms typically require weeks to months of therapy for meaningful improvement, making true palliation unlikely in the comfort-care timeframe. 2, 3

2. Patient/Family Preference After Informed Discussion

If the patient or family requests antibiotics after understanding that they will not cure the infection or prolong meaningful life, continuation may align with patient-centered care. 1, 4 Document this discussion clearly, including:

  • Antibiotics will not cure osteomyelitis without surgery. 2
  • Expected survival is measured in hours to days, not weeks. 1, 4
  • Risks include IV line complications, drug side effects, and potential discomfort. 1, 4
  • The primary goal remains comfort, not infection control. 1

Evidence from Clinical Practice

In a retrospective study of 711 hospitalized patients alive ≥24 hours after comfort-care orders, only 15.6% remained on antimicrobials. 4 Among those who continued antibiotics, only 26% had documented patient/family preference and 26% had documented symptom palliation as the rationale. 1 This suggests that most clinicians appropriately discontinue antibiotics when transitioning to comfort care. 1, 4

Another study found that 41% of providers "sometimes" or "often" continued antimicrobials during the transition to comfort-measures-only, with patient/family preference and symptom palliation being the most common cited factors. 1 However, there is limited evidence that antibiotics provide meaningful palliative benefit in the short timeframe of comfort care. 1

Practical Algorithm for Decision-Making

Step 1: Confirm the goals of care are truly comfort-focused (no curative intent, no surgical intervention planned). 1, 4

Step 2: Assess whether antibiotics are providing symptom relief:

  • Is the patient febrile, and does fever cause distress? 1
  • Is there purulent drainage causing discomfort? 1
  • Have symptoms improved since starting antibiotics? 1

Step 3: If antibiotics are NOT providing clear symptom relief, discontinue them. 1, 4

Step 4: If the patient/family requests continuation despite lack of palliative benefit:

  • Explain that osteomyelitis requires 4–6 weeks of antibiotics PLUS surgery for cure. 2, 3
  • Clarify that antibiotics will not extend meaningful life in comfort care. 1, 4
  • Discuss risks: IV line complications, drug toxicity, and potential discomfort. 1, 4
  • If they still request continuation, honor this preference and document the discussion. 1

Step 5: If antibiotics are continued, reassess daily and discontinue if no benefit or if the patient becomes unable to tolerate IV access. 1, 4

Critical Pitfalls to Avoid

  • Do not continue antibiotics by default without reassessing goals of care and symptom burden. 1, 4
  • Do not assume antibiotics provide comfort without clear evidence of symptom improvement. 1
  • Do not continue IV antibiotics if the patient is distressed by IV access or if access becomes difficult. 1, 4
  • Do not use antibiotics to avoid difficult conversations with patients/families about prognosis and goals of care. 1

Special Considerations for This Case

This resident has polymicrobial osteomyelitis (MRSA, Pseudomonas aeruginosa, anaerobes), which typically requires broad-spectrum IV antibiotics (e.g., vancomycin + cefepime + metronidazole) for 6–8 weeks PLUS surgical debridement for any chance of cure. 5, 6, 2 In comfort-measures-only care, this aggressive regimen is neither feasible nor aligned with the patient's goals. 1, 4

The most appropriate course is to discontinue antibiotics unless the patient has distressing symptoms (fever, pain, purulent drainage) that clearly improve with antimicrobial therapy, or unless the patient/family explicitly requests continuation after informed discussion. 1, 4

References

Research

Treating osteomyelitis: antibiotics and surgery.

Plastic and reconstructive surgery, 2011

Research

Bacterial osteomyelitis: microbiological, clinical, therapeutic, and evolutive characteristics of 344 episodes.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment for Osteomyelitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.